# Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease

> **NCT01669876** · PHASE2 · TERMINATED · sponsor: **Rock Creek Pharmaceuticals, Inc.** · enrollment: 85 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Anatabloc(R)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01669876
- **Lead sponsor:** Rock Creek Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** Administrative status of active ingredient anatabine
- **Last updated:** 2015-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669876, "Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01669876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*